| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/22/1993 | CA2128331A1 Methods for using histamine derivatives as immunomodulators and in immunotherapeutics |
| 07/22/1993 | CA2128212A1 Detoxified lps-cholera toxin conjugate vaccine for prevention of cholera |
| 07/22/1993 | CA2128211A1 A major histocompatibility complex class ii antigen in a vaccine against an immunodeficiency virus |
| 07/22/1993 | CA2127991A1 Preparation of antigens of and of vaccines for the virus of mystery disease, antigens and vaccines obtained for the prevention of this disease |
| 07/22/1993 | CA2127550A1 Multifunctional surface protein of streptococci |
| 07/22/1993 | CA2127532A1 Antibodies recognizing the fourth immunoglobulin-like domain of vcam1 |
| 07/22/1993 | CA2127466A1 Feline leukemia virus vaccines |
| 07/22/1993 | CA2127368A1 Platelet transfusion |
| 07/22/1993 | CA2126094A1 Induced tolerence to xenografts |
| 07/22/1993 | CA2125701A1 Hepatitis e virus vaccine and method |
| 07/22/1993 | CA2125700A1 Hepatitis e virus peptide antigens and antibodies |
| 07/22/1993 | CA2124217A1 Inactivation of cytotoxic drugs |
| 07/22/1993 | CA2105284A1 Dna encoding a human 5-ht 1f receptor and uses thereof |
| 07/21/1993 | EP0552031A1 Oxepane isomers of rapamycin useful as immunosuppressive agents |
| 07/21/1993 | EP0551689A2 Cyclic HIV principal neutralizing determinant (PNP) peptides |
| 07/21/1993 | EP0551671A1 Treponema hyodysenteriae vaccine |
| 07/21/1993 | EP0551506A1 System for protein expression and secretion especially in corynebacteria |
| 07/21/1993 | EP0551501A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
| 07/21/1993 | EP0551460A1 HCV peptide-antigens and a method of testing for the hepatitis C virus (HCV) |
| 07/21/1993 | EP0551449A1 Method for producing a subunit vaccine against porcine parvovirus |
| 07/21/1993 | EP0551446A1 A onco-fetal gene, gene product and uses therefor |
| 07/21/1993 | EP0551442A1 Self-assembling ion pair drugs |
| 07/21/1993 | EP0551440A1 Design of bioactive peptides based on immunoglobulin structure |
| 07/21/1993 | EP0551400A1 Method for treating inflammation using anti-idiotypic antibodies |
| 07/21/1993 | EP0551308A1 Novel peptide antigens and immunoassays, test kits and vaccines using the same |
| 07/21/1993 | EP0551301A1 Cd53 cell surface antigen and use thereof |
| 07/21/1993 | EP0462187B1 Pharmaceutical composition useful in the prevention or treatment of papillomavirus-induced tumours |
| 07/21/1993 | EP0242359B1 A cloning vehicle for cloning a large fragment of dna and a vaccine comprising 987p fimbrial protein |
| 07/21/1993 | EP0179887B1 Adhesin antigens, antibodies and dna fragment encoding the antigen, methods and means for diagnosis and immunization etc. |
| 07/21/1993 | CN1074377A A composition used as a therapeutic agent against chronic viral hepatic diseases |
| 07/20/1993 | US5229495 Transforming growth factor |
| 07/20/1993 | US5229293 Recombinant baculovirus |
| 07/20/1993 | US5229289 Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human and with synthetic carbohydrate-carrier conjugates |
| 07/20/1993 | US5229272 Catalytic antibody components |
| 07/20/1993 | US5229115 Adoptive immunotherapy with interleukin-7 |
| 07/20/1993 | US5229111 Method of inhibiting picornavirus disease |
| 07/20/1993 | US5229110 Process for preparing a vaccine against malaria |
| 07/20/1993 | CA1320466C Process for the preparation of capsular polysaccharides of staphylococci, the polysaccharides obtained, uses of these polysaccharides and strains for carrying out of the process |
| 07/20/1993 | CA1320460C Anti-human gastric cancer monoclonal antibody |
| 07/20/1993 | CA1320350C Combination lock for blood identification system |
| 07/14/1993 | EP0550955A2 Chimeric antibody against human GMP-140 |
| 07/14/1993 | EP0550946A2 Genes encoding porcine zona pellucida protein PZP-4, expression thereof and contraceptive vaccines comprising expressed (poly)peptides |
| 07/14/1993 | EP0550663A1 Modified antibodies with controlled clearance time |
| 07/14/1993 | EP0550599A1 Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
| 07/14/1993 | EP0550561A1 Purification of cytokeratin fragments |
| 07/14/1993 | EP0550558A1 Acellular vaccine |
| 07/14/1993 | EP0550553A1 Viral defective vaccine produced by transcomplementing cell line |
| 07/14/1993 | EP0550500A1 NUCLEOTIDE AND AMINO ACID SEQUENCES OF PROTEIN MTP40 OF $i(M. TUBERCULOSIS) AND SYNTHETIC PEPTIDES DERIVED THEREFROM |
| 07/14/1993 | EP0550485A1 DERIVATIVES OF gp160 AND VACCINES BASED ON gp160 OR A DERIVATIVE THEREOF, CONTAINING AN ADJUVANT |
| 07/14/1993 | EP0550482A1 Methods for inhibiting rejection of transplanted tissue |
| 07/14/1993 | EP0550465A1 Entamoeba histolytica immunodominant surface antigens |
| 07/14/1993 | EP0550453A1 Interleukin-2-leukotoxin gene fusions and uses thereof |
| 07/14/1993 | CN1074135A Adjuvants |
| 07/14/1993 | CN1021543C Vaccine of pork measies and its preparation |
| 07/13/1993 | US5227369 Carbohydrate blocking agent which inhibits LHR-mediated binding of leukocytes to myelin |
| 07/13/1993 | US5227160 Contraceptives, treatment of infertility |
| 07/13/1993 | CA1320196C Immunostimulating guanine derivatives, compositions and methods |
| 07/13/1993 | CA1320163C Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus |
| 07/13/1993 | CA1320160C Monoclonal antibodies against ifn-omega, processes for preparing them and their use in the purification and detection of ifn-omega |
| 07/08/1993 | WO1993014110A1 Method for isolating biomolecules with linear polymers |
| 07/08/1993 | WO1993013421A1 Immunochemical detection of in vivo advanced glycosylation endproducts |
| 07/08/1993 | WO1993013209A1 Expression signal-peptide-free staphylokinases |
| 07/08/1993 | WO1993013203A1 Hybrid cells producing an antigen characteristic of the hepatitis b virus |
| 07/08/1993 | WO1993013202A1 Immunogenic detoxified mutants of cholera toxin and of the toxin lt, their preparation and their use for the preparation of vaccines |
| 07/08/1993 | WO1993013130A1 Somatostatin receptors |
| 07/08/1993 | WO1993013127A1 Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus |
| 07/08/1993 | WO1993013089A1 Macrocyclic polyether carboxylic acids |
| 07/08/1993 | WO1993012816A1 Monoclonal antibodies against type i phospholipase a2, used as a therapeutic agent to reduce inflammation |
| 07/08/1993 | WO1993012815A1 Method for obtaining recombinant surface antigen of hepatitis b, antigen and vaccine based on it |
| 07/08/1993 | WO1993012814A2 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 07/08/1993 | WO1993012756A2 Transfection of lung via aerosolized transgene delivery |
| 07/08/1993 | WO1993012755A2 Detection of alzheimer's disease and other diseases using a photoaffinity labeling method |
| 07/08/1993 | CA2126693A1 Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus |
| 07/08/1993 | CA2126686A1 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations |
| 07/08/1993 | CA2126209A1 Immunochemical detection of in vivo advanced glycosylation endproducts |
| 07/08/1993 | CA2104772A1 Method for isolating biomolecules with linear polymers |
| 07/07/1993 | EP0550400A2 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 07/07/1993 | EP0550020A2 Anti-human IgE monoclonal antibodies |
| 07/07/1993 | EP0549711A1 Natural killer stimulatory factor |
| 07/07/1993 | EP0549662A1 Plasmodium liver stage antigens |
| 07/07/1993 | CN1073889A Multile emulsions and methods of preparation |
| 07/07/1993 | CN1073879A Chicken anaemia agent vaccine |
| 07/07/1993 | CN1073878A Expression of specific immunogens using viral antigens |
| 07/06/1993 | US5225542 Specific carbohydrate-binding proteins (lectins) of mammalian tumor cells |
| 07/06/1993 | US5225540 Hybridomas and Fab fragments |
| 07/06/1993 | US5225534 Immunology for malaria |
| 07/06/1993 | US5225530 Polypeptide useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of malarial affections |
| 07/06/1993 | US5225337 Ribozyme compositions and methods for use |
| 07/06/1993 | US5225336 Recombinant poxvirus host range selection system |
| 07/06/1993 | US5225331 Immunoassay for detecting group b streptococcus |
| 07/06/1993 | US5225324 Diagnostics for mycobacteria in public health, medical, and veterinary practice |
| 07/06/1993 | US5225194 Aqueous diafiltration process for preparing acellular vaccines, against selected bacterial diseases |
| 07/06/1993 | US5225193 Bordetella toxin peptides and vaccines |
| 07/01/1993 | CA2058598A1 Specific dna sequences related to an ibdv protein including vectors, hosts and vaccines |
| 06/30/1993 | EP0549074A1 Adjuvants |
| 06/30/1993 | EP0549066A1 Serpulina hyodysenteriae vaccine |
| 06/30/1993 | EP0548357A1 Treatment of hair loss and dermatological problems |
| 06/30/1993 | EP0548252A1 Genetically engineered coccidiosis vaccine |
| 06/30/1993 | EP0548234A1 Cloning of chicken anaemia dna |
| 06/30/1993 | EP0548210A1 Liposomes |